Lisheng Pharmaceutical's net profit in 2025 is 418 million yuan, a year-on-year increase of 126.72%

Beijing Business Daily (Reporter Ding Ning) March 9th — Lisheng Pharmaceutical (002393) announced its 2025 performance forecast on the evening of March 9th, showing that the company achieved an operating revenue of 1.393 billion yuan in 2025, a year-on-year increase of 4.23%; net profit attributable to shareholders was 418 million yuan, a year-on-year increase of 126.72%.

Lisheng Pharmaceutical stated that during the reporting period, the company actively expanded its market and increased product sales. Additionally, influenced by dividends from its equity investments, the total profit and net profit attributable to shareholders saw significant year-on-year growth.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin